SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
Titre
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
Sujet
Description
Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose of the mRNA-1273 vaccine (Moderna) and 95% efficacy at 7 days after the second dose of the BNT162b2 vaccine (Pfizer).
Date
2021-03-23
Type
Citer ce document
Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani. 2021. "SARS-CoV-2 Infection after Vaccination in Health Care Workers in California." New England Journal of Medicine.
Accessibilité
Free online on NEJM.
Was this resource helpful?